Gating of the Purified Human Cardiac Ryanodine Receptor (hRyR2) in the Absence of Regulatory Accessory Proteins  by Mukherjee, Saptarshi et al.
302a Monday, February 22, 2010extent with 1.0 mM Ca2þ than control RyR2 (Po was 5X greater in diabetic
RyR2). Two weeks of insulin treatment blunted the enhanced Ca2þ responsive-
ness. When added to the cis chamber the potent reactive carbonyl species
(RCS), 80 mM methylglyoxal increased the open probability (Po) of RyR2 3-
fold (0.05 to 0.16) within 10 min and this increase was independent of holding
potential. Increasing [MGO] further to 160 mM, reduced the conductance of
RyR2 by 25% without changing Po. Incubating RyR2 with MGO (5-500 mM
with 200 mM free Ca2þ in buffer) dose-dependently reduced its ability to bind-
ing [3H]ryanodine. Singly mutating R1611, R2190 and K2888 to W or Y, to
mimic adducts previously found on them during diabetes, resulted in gain-of-
function of RyR2 (Po increased >2-fold at 3.3 mM Ca
2þ ). Mutating c-terminal
R4462, and R4683 toW or Y resulted in loss-of function of RyR2.We conclude
that modification of RyR2 by RCS during diabetes is responsible in part for its
dysregulation. (This work was funded by NIH and Nebraska Redox Biology
Center)
1573-Pos
Gating of the Purified Human Cardiac Ryanodine Receptor (hRyR2) in the
Absence of Regulatory Accessory Proteins
Saptarshi Mukherjee, Nia Lowri Thomas, Laila Guzadhur,
Chloe E. Maxwell, Alan J. Williams.
Cardiff University, Cardiff, United Kingdom.
The cardiac ryanodine receptor (RyR2) mediates Ca2þ efflux from intracellular
stores to effect myocyte contraction during excitation-contraction coupling.
Mutations in this channel perturb Ca2þ release function, leading to triggered
arrhythmias that may cause sudden cardiac death (SCD). The exact molecular
mechanisms by which SCD-linked RyR2 dysfunction occurs constitutes a bur-
geoning area of cardiac research. Most studies so far have concentrated on the
secondary effects of mutation on channel function by virtue of affecting chan-
nel modification by phosphorylation and accessory protein binding, with no
great emphasis on elucidating the gating mechanisms of the channel itself.
Our aim is to elucidate the mechanistic basis of wild-type (WT) hRyR2 activa-
tion by its primary activating ligand, Ca2þ, under precisely controlled condi-
tions in the absence of any accessory proteins with a view to determining the
effect of mutation on hRyR2 gating in the same way. hRyR2 channels, recom-
binantly expressed in HEK293 cells, were purified and studied at the single
channel level in symmetrical 210mM KCl under reducing conditions. Trans
(luminal) Ca2þ was buffered at 50nM using EGTA, while cis (cytosolic)
Ca2þ buffering was stringently controlled using EGTA, HEDTA and NTA to
achieve free Ca2þ concentrations in the range of 0-500 mM. Preliminary data
obtained from sigmoidal dose-response curves of Po vs pCa for 10 WT
hRyR2 channels yields an EC50 of 3.2551.04 mM, resulting in a maximum
Po greater than 0.8 (in 5 out of 10 channels). This increase in Po resulted
from an increase in the frequency of channel openings, until Po of 0.8 - above
which any increases in Po resulted from an increase in open times. Likely gating
mechanisms will be discussed with a view to mutant channel analysis.
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The biological methyl group donor, S-adenosyl-L-methionine (SAM) activates
the cardiac ryanodine receptor (RyR2). Previously we investigated the mecha-
nism underlying SAM regulation of RyR2 with [3H]ryanodine binding to car-
diac SR vesicles. SAM enhances Ca2þ -activation of RyR2 and increases the
apparent affinity of ryanodine for the channel. Notably, methyltransferase in-
hibitors have no effect on SAM-activation, and SAM-mediated methylation
of RyR2 is not detected. Furthermore, the concentration dependence for
SAM and ATP-induced increase in [3H]ryanodine binding overlap. Presently,
we investigated the affect of SAM on native RyR2 channels incorporated
into planar lipid bilayers. Channel were grouped according to initial Po values
under control conditions (10 mM cytosolic Ca2þ), those with Po < 0.2 (n=7),
and Po > 0.2 (n=5). For channels with an initial Po < 0.2, SAM caused a rapid
(within seconds) increase in Po (p< 0.05). The SAM-induced increase in Po was
due primarily to an increase in mean open time (p<0.05; n¼3). Interestingly,
SAM activation was associated with an increased frequency of subconduca-
tance states. In contrast, the increase in channel Po caused by 2mM ATP
was not associated with the appearance of subconductance states. Thus, the ef-
fect on subconductance states appears specific to SAM. This work highlights
the complexity underlying SAM regulation of RyR2. The data suggest ligand
binding is among the multiple mechanisms responsible for SAM-activation
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HLP is a heart-specific LIM-only protein having two LIM domains each con-
sisting of two zinc fingers. Through the bacterial 2 hybrid screening and a fol-
lowing LC-MS/MS study, we have found that HLP interacts with the cytosolic
divergent region of mouse heart RyR2. The direct interaction between RyR2
and HLP was confirmed by GST pull-down and co-immunoprecipitation as-
says. HLP was partially co-localized with RyR2 in HL-1 cells and rat adult car-
diomyocytes. siRNA or Adenovirus-mediated knock-down of HLP in HL-1
cells and neonatal cardiomyocytes led to more than 70% decrease in the expres-
sion of HLP, without a concomitant change of other Ca2þ handling proteins
(e.g. SERCA, RyR2, calsequestrin and DHPR). Ca2þ transient measurement
of fura2-loaded cardiomyocytes by 1Hz field stimulation demonstrated that si-
lencing of HLP decreased the peak amplitude of Ca2þ transient (~ 15%) in HL-
1 cells and in neonatal cardiomyocytes. Currently, various deletion-mutants of
LIM protein are being used to characterize the RyR2 binding sites in HLP.
(This work was supported by the Korean Ministry of Science and Technology
grant, Systems Biology Research Grant, M1050301001-6N0301-0110, and the
2009 GIST Systems Biology Infrastructure Establishment Grant).
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Canonical-type transient receptor potential cation channel type 3 (TRPC3) in
plasma membrane allows the entry of Ca2þ ions into various cells. In skeletal
myotubes, functional interaction between TRPC3 and RyR1 (ryanodine recep-
tor1, a Ca2þ channel in sarcoplasmic reticulum (SR) membrane) regulates the
gain of skeletal excitation-contraction coupling (J. Biol. Chem., 2006). Mitsu-
gumin-29 (MG29) is a four membrane-spanning protein and is found in both
plasma and SR membrane. MG29 has been known as a TRPC3-interacting pro-
tein in skeletal myotubes (Biochem. J., 2008).
To identify critical region(s) of MG29 that participate in binding to TRPC3 or
the role of MG29 in skeletal muscle, N-terminus, three intervenient loops
among four transmembrane regions, and C-terminus of MG29 were expressed
in E. coil as N-terminal GST-fused forms, and subjected to co-immunoprecip-
itation assay with intact TRPC3 from rabbit skeletal muscle. Cytoplasmic N-
terminus and a loop between first and second transmembrane domains of
MG29 effectively bound to TRPC3. Two deletion mutants of MG29 (missing
the TRPC3-binding sites: deleting the N-terminus only or longer N-terminus
covering the loop region) was expressed in mouse skeletal myotubes, and the
myotubes was subjected to the measurement of Ca2þ transients with Fura-2
or Fluo-4. The later mutant showed significantly decreased responsiveness of
RyR1 to caffeine, suggesting that MG29 may be a mediator between the func-
tional interaction between TRPC3 and RyR1.
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Phosphorylation status appears to be a key determinant of excitation-contrac-
tion coupling ion channel and pump function. Dysfunction of the ryanodine re-
ceptor (RyR) secondary to catecholaminergic drive and phosphorylation has
been proposed as a factor in contractile dysfunction and arrhythmia patho-phys-
iology in the failing heart. The phosphorylation states of RyR, along with those
of phospholamban and troponin I have been investigated by immunoblotting,
and quantitated by comparing levels in failing hearts with basal levels, mini-
mum levels after beta-blocker treatment and maximal levels achieved by ex
vivo treatment with isoprenaline. We found that RyR residue Ser2809 was
phosphorylated to 124 5 11 % (n ¼ 5, P > 0.05) of control (sham-operated,
basal) in heart failure under basal conditions and 143 5 12 % (n ¼ 6, P <
0.05) with isoprenaline treatment, and residue Ser2030 was 94 5 10 % (n ¼
8, P > 0.05) for heart failure and 1995 9 % (n=6, P < 0.05) for isoprenaline
treatment. Phosphorylation levels at Ser16 of phospholamban were higher:
159 5 17 % (heart failure, n ¼ 7, P < 0.05) and 366 5 95 % (isoprenaline
treatment, n ¼ 5, P < 0.05). At Ser23/24 of troponin I there is no significant
